Coronavirus: Vaccination

Foreign, Commonwealth and Development Office written question – answered on 15th February 2021.

Alert me about debates like this

Photo of Clive Lewis Clive Lewis Labour, Norwich South

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what assessment the Government has made of the effect on global equality of access to the covid-19 vaccines in the event that the proposed WTO TRIPS Waiver is not adopted.

Photo of Wendy Morton Wendy Morton Parliamentary Under-Secretary (Foreign, Commonwealth and Development Office)

The UK is committed to rapid equitable access to safe and effective vaccines, and is playing a leading role in financing the global effort, and identifying solutions that ensure affordable access for all.

The UK Government does not consider waiving intellectual property (IP) rights to be an appropriate course of action in boosting the manufacturing of safe, effective, and quality vaccines. The existing intellectual property framework has mobilised research and development to deliver a host of new medicines and technologies to detect, treat, and defend against COVID-19. The incentives and access mechanisms provided by the IP framework have been integral to this success, without which we would not have seen the impressive surge of research and development, and the unprecedented scaling up of production.

Does this answer the above question?

Yes2 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.